It's got to be noted that the BOD did > say that they would give some Priority to 8 of the 20+ programs in the APIRX portfolio.
The first step is getting the manufacturing underway > this week we have seen two advances on that front with a further six remaining on the short-term priorities list.
For me, this is all about adding value to the share price in 2025/6 and beyond. I am starting to get a clearer idea now of where our longer-term value is heading.
CLICK THE IMAGE TO ENLARGE
I also note that the next steps for Can Quit and Rene Cann are Pre-IND meetings, (the manufacturing side will be needed to add data to support the Pre-Ind meeting) the other programs may or may not need manufacturing agreements also before progressing further.
GLAH
IHL Price at posting:
23.8¢ Sentiment: Buy Disclosure: Held
